TRIM64C: A Potential Drug Target and Biomarker (G646754)

Target Name: TRIM64C

NCBI ID: G646754

TRIM64C

TRIM64C: A Potential Drug Target and Biomarker

TRIM64C, also known as Tripartite motif-containing protein 64C, is a protein that has been identified as a potential drug target and biomarker. Its unique structure and function have made it an attractive target for researchers to study, and its potential as a drug may have significant implications for the treatment of various diseases.

The TRIM64C protein is a member of the TRIM gene family, which is known for the production of structurally diverse proteins that play important roles in various cellular processes. The TRIM64C protein is characterized by its unique tripartite motif, which consists of three distinct domains: a N-terminal alpha-helix, a middle尾-sheet, and a C-terminal alpha-helix. This unique structure has been conserved in various species, and its presence indicates that TRIM64C may have important functions in different cellular processes.

One of the key features of TRIM64C is its ability to form inclusion bodies, which are protein structures that can interact with and modulate the activity of other proteins. These inclusion bodies are formed by the association of multiple TRIM64C proteins with one another, and they have has been shown to play important roles in various cellular processes, including cell signaling, protein folding, and stress response.

In addition to its ability to form inclusion bodies, TRIM64C is also known for its unique expression patterns. The TRIM64C gene is expressed in various tissues and cells of the body, including the brain, heart, and gastrointestinal tract. However, the levels of TRIM64C The protein varies significantly depending on the specific cell type and the tissue in which it is expressed. This variable expression pattern may be a potential target for researchers to study the effects of different treatments on TRIM64C expression.

TRIM64C has also been shown to play important roles in various cellular processes that are relevant to a wide range of diseases. For example, TRIM64C has been shown to be involved in the regulation of cell signaling pathways that are important for various cellular processes, including cell growth, differentiation, and stress response. In addition, TRIM64C has also been shown to play important roles in the regulation of protein folding and stability, which are important for the production and function of a wide range of proteins.

Given its unique structure and function, TRIM64C has been identified as a potential drug target. By modulating the activity of TRIM64C, researchers may be able to develop new treatments for a wide range of diseases. For example, TRIM64C has been shown to be involved in the regulation of cell signaling pathways that are important for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, targeting TRIM64C with drugs that modulate its activity may be a promising approach to the treatment of these diseases.

In addition to its potential as a drug target, TRIM64C has also been identified as a potential biomarker. Its unique expression patterns and ability to form inclusion bodies make it an attractive candidate for use as a diagnostic marker or therapeutic target. For example, TRIM64C has has been shown to be expressed in various diseases, including cancer, and its levels may be used as a biomarker to diagnose or monitor the effectiveness of treatments for these diseases.

Overall, TRIM64C is a protein that has significant potential as a drug target and biomarker. Its unique structure and function have made it an attractive target for researchers to study, and its potential as a drug or biomarker may have significant implications for the treatment of various diseases. Further research is needed to fully understand the functions of TRIM64C and its potential as a drug

Protein Name: Tripartite Motif Containing 64C

The "TRIM64C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRIM64C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets